Ulnar Wrist Pain Treatment With Dextrose Prolotherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-01

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants who have failed therapy for chronic wrist pain on the little finger side of the wrist will recieve dextrose prolotherapy. Their results will be compared to a cohort of consecutive participants who have not failed therapy, and receive 4 weeks of usual care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Ultrasound-Guided PRP Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at Elbow

NCT05567081

Ulnar Neuropathy at Elbow

COMPLETED PHASE2/PHASE3

Delto-Tricipital Compression Syndrome: Treated With Injection of Dextrose

NCT02331069

Superficial Radial Nerve Lesion

UNKNOWN NA

Blood Flow Restriction for Ulnar Sided Wrist Pain

NCT06963671

Ulnar Wrist Pain

ENROLLING_BY_INVITATION NA

Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow

NCT04264000

Ulnar Neuropathy at Elbow

COMPLETED NA

Study of Single Platelet-Rich Plasma Local Injection Vs. Single Corticosteroid Local Injection in Carpal Tunnel Syndrome

NCT06209957

Carpal Tunnel Syndrome

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulnar Wrist Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Participants are assigned to one of two groups in parallel. After that the study becomes one arm as both groups are offered dextrose.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type OTHER

Therapeutic ultrasound, myofascial release of extensor and flexor muscles of forearm and stabilization exercises for the wrist.

Dextrose

Group Type EXPERIMENTAL

Dextrose

Intervention Type PROCEDURE

Injection of 1 ml of 12.5% dextrose in 1% lidocaine at 0, 3 and 6 weeks in 5 locations: Origin of ulnar collateral ligament, insertion of ulnar collateral ligament on the triquetrum, insertion of the extensor carpi ulnaris on the base of the 5th metacarpal, triquetral hamate ligament and ulnotriquetral joint space.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Usual Care

Therapeutic ultrasound, myofascial release of extensor and flexor muscles of forearm and stabilization exercises for the wrist.

Intervention Type OTHER

Dextrose

Injection of 1 ml of 12.5% dextrose in 1% lidocaine at 0, 3 and 6 weeks in 5 locations: Origin of ulnar collateral ligament, insertion of ulnar collateral ligament on the triquetrum, insertion of the extensor carpi ulnaris on the base of the 5th metacarpal, triquetral hamate ligament and ulnotriquetral joint space.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pain on the ulnar side of the wrist.
* PRWE greater than 40

Exclusion Criteria

* Radioulnar instability more than moderate as determined by a positive ulna fovea sign or ulna grinding test
* Surgery in the wrist area
* Infection in the wrist area
* Other wrist pathology on examination
* Other pain area that is constant, interferes with sleep, or is as bad, or worse, than shoulder pain.
* Diabetes or other peripheral neuropathy
* Radiculopathy
* Unstable psychiatric function.
* Current opioid use.
* Vulnerable patients
* Pregnancy

Minimum Eligible Age

21 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No